Device Trial Radar · NCT06384183
Kerecis Real-World Fish Skin Graft Registry
Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
600
Planned (sponsor's estimate)
Start
Aug 7, 2024
Primary completion
Dec 2026
Study completion Dec 2027
Sponsor
- Lead sponsor
- Kerecis Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 25, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multi-center, observational (i.e., non-interventional), open-label, real-world Registry on the Use of Kerecis Devices
Conditions
- Wounds
- Pressure Ulcer
- Diabetic Foot Ulcer
- Venous Leg Ulcer
- Surgical Wound
- Soft Tissue Reinforcement
Interventions
Kerecis Fish Skin GraftDevice
Patients already treated with a Kerecis device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Fish Skin Graft Device Related failureTime frame: 12 months
- Fish Skin Graft Device related allergyTime frame: 12 months
- Target Wound InfectionTime frame: 12 months
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
University Park
Sarasota, Florida
Cone Health Ortho Care Greensboro
Greensboro, North Carolina
Feet First Institute of Beavercreek
Beavercreek, Ohio
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.